First report of OXA-23-mediated carbapenem resistance in sequence type 2 multidrug-resistant Acinetobacter baumannii associated with urinary tract infection in a cat

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 2, 2014, Pages 1267-1268

  Pomba, Constança ^a   Endimiani, Andrea ^b   Rossano, Alexandra ^b   Saial, Dolores ^a   Couto, Natacha ^a   Perreten, Vincent ^b  

^a FACULDADE DE MEDICINA VETERINÁRIA   (Portugal)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLAVULANIC ACID; COLISTIN; IMIPENEM; KANAMYCIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; PROTEIN OXA 23; STREPTOMYCIN; SULFAMETHOXAZOLE; TETRACYCLINE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CAT; DNA DNA HYBRIDIZATION; LETTER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRANSPOSON; URINARY TRACT INFECTION;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARBAPENEMS; CAT DISEASES; CATS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION; URINARY TRACT INFECTIONS;

EID: 84893433160     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02527-13     Document Type: Letter

References (14)

1. Poirel L, Nordmann P. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12: 826-836. http://dx.doi.org/10.1111/j.1469-0691.2006.01456.x.
2. Mugnier PD, Poirel L, Naas T, Nordmann P. 2010. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg. Infect. Dis. 16:35-40. http://dx.doi.org/10.3201/eid1601.090852.
3. Poirel L, Berçot B, Millemann Y, Bonnin RA, Pannaux G, Nordmann P. 2012. Carbapenemase-producing Acinetobacter spp. in cattle, France. Emerg. Infect. Dis. 18:523-525. http://dx.doi.org/10.3201/eid1803.111330.
4. Smet A, Boyen F, Pasmans F, Butaye P, Martens A, Nemec A, Deschaght P, Vaneechoutte M, Haesebrouck FJ. 2012. OXA-23-producing Acinetobacter species from horses: a public health hazard? J. Antimicrob. Chemother. 67:3009-3010. http://dx.doi.org/10.1093/jac/dks311.
5. Zhang WJ, Lu Z, Schwarz S, Zhang RM, Wang XM, Si W, Yu S, Chen L, Liu S. 2013. Complete sequence of the blaNDM-1-carrying plasmidpNDM-AB from Acinetobacter baumannii of food animal origin. J. Antimicrob. Chemother. 68:1681-1682. http://dx.doi.org/10.1093/jac/dkt066.
6. Endimiani A, Hujer KM, Hujer AM, Bertschy I, Rossano A, Koch C, Gerber V, Francey T, Bonomo RA, Perreten V. 2011. Acinetobacter baumannii isolates from pets and horses in Switzerland: molecular characterization and clinical data. J. Antimicrob. Chemother. 66:2248-2254. http://dx.doi.org/10.1093/jac/dkr289.
7. Clinical and Laboratory Standards Institute. 2013. Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. CLSI document M100-S23. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Card R, Zhang J, Das P, Cook C, Woodford N, Anjum MF. 2013. Evaluation of an expanded microarray for detecting antibiotic resistance genes in a broad range of Gram-negative bacterial pathogens. Antimicrob. Agents Chemother. 57:458-465. http://dx.doi.org/10.1128/AAC.01223-12.
9. Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, Ecker DJ, Massire C, Eshoo MW, Sampath R, Thomson JM, Rather PN, Craft DW, Fishbain JT, Ewell AJ, Jacobs MR, Paterson DL, Bonomo RA. 2006. Analysis of antibiotic resistance genes in multidrugresistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob. Agents Chemother. 50:4114-4123. http://dx.doi.org/10.1128/ AAC.00778-06.
10. Bonnin RA, Rotimi VO, Al Hubail M, Gasiorowski E, Al Sweih N, Nordmann P, Poirel L. 2013. Wide dissemination of GES-type carbapenemases in Acinetobacter baumannii isolates in Kuwait. Antimicrob. Agents Chemother. 57:183-188. http://dx.doi.org/10.1128/AAC.01384-12.
11. Corvec S, Poirel L, Naas T, Drugeon H, Nordmann P. 2007. Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii. Antimicrob. Agents Chemother. 51:1530-1533. http://dx.doi.org/10.1128/AAC.01132-06.
12. Héritier C, Poirel L, Nordmann P. 2006. Cephalosporinase overexpression resulting from insertion of ISAba1 in Acinetobacter baumannii. Clin. Microbiol. Infect. 12:123-130. http://dx.doi.org/10.1111/j.1469-0691.2005. 01320.x.
13. Grosso F, Quinteira S, Peixe L. 2011. Understanding the dynamics of imipenem resistant Acinetobacter baumannii lineages within Portugal. Clin. Microbiol. Infect. 17:1275-1279. http://dx.doi.org/10.1111/j.1469-0691.2011. 03469.x.
14. Manageiro V, Jones-Dias D, Ferreira E, Louro D, Antimicrobial Resistance Surveillance Program in Portugal, Caniça M. 2012. Genetic diversity and clonal evolution of carbapenem-resistant Acinetobacter baumannii isolates from Portugal and the dissemination of ST118. Int. J. Antimicrob. Agents. 40:398-403. http://dx.doi.org/10.1016/j.ijantimicag.2012.06.013.